What's in Istituto Auxologico Italiano's pipeline?

Istituto Auxologico Italiano has 9 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 6 in Phase 2, 1 in Phase 1.

Which companies overlap with Istituto Auxologico Italiano's portfolio?

Top competitors by shared drug class: ATS Clinical Research, Eurofarma Laboratorios S.A., Faculdade de Medicina do ABC, Hanmi Pharmaceutical Company Limited, InnoPharmax Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/istituto-auxologico-italiano.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Istituto Auxologico Italiano — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Istituto Auxologico Italiano pipeline: 2 marketed, 0 filed, 0 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 6 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
enalapril tablets	enalapril tablets	marketed
Losartan Tablets	Losartan Tablets	marketed	Angiotensin II receptor antagonist (ARB)	AT1 receptor (angiotensin II type 1 receptor)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ATS Clinical Research · 1 shared drug class
Eurofarma Laboratorios S.A. · 1 shared drug class
Faculdade de Medicina do ABC · 1 shared drug class
Hanmi Pharmaceutical Company Limited · 1 shared drug class
InnoPharmax Inc. · 1 shared drug class
Nara Medical University · 1 shared drug class
Novartis · 1 shared drug class
Shanghai Mental Health Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Istituto Auxologico Italiano:

Cite this brief

Drug Landscape (2026). Istituto Auxologico Italiano — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/istituto-auxologico-italiano. Accessed 2026-05-17.